eHealth and the use of individually tailored information: A systematic review

eHealth and the use of individually tailored information: A systematic review
复制标题

DOI:
10.1177/1460458216641479
复制
发表时间:
2017-09-01
影响因子:
3
通讯作者:
Wake, Deborah
Wake, Deborah
中科院分区:
医学3区
文献类型:
--
作者:
Conway, Nicholas;Webster, Clare;Wake, Deborah

文献摘要

被引文献

相似文献

量身定制的信息是那些在对个人独特特征进行评估后专门针对个人的信息。这项系统的审查评估了关于针对慢性病管理的电子健康干预措施中量身定做的有效性的证据。在Ovid Medline/Embase数据库中搜索从2014年5月开始的随机对照试验、对照临床试验、前后研究和时间序列分析。客观测量的临床过程/结果被考虑在内。22篇论文符合纳入条件:6/22使用了完全定制的电文,16/22使用了部分定制的电文。两项研究分离出剪裁作为活性成分。其余的人将干预与标准护理进行比较。总体而言,无论目标人群如何,12/16项衡量临床过程的研究和2/6项报告临床结果的研究都显示出改善。研究质量低,设计不允许确定干预措施的有效成分。异质性排除了荟萃分析。这项综述表明,缺乏证据表明,在电子健康背景下进行定制比非定制的电子健康干预措施更有好处。
Tailored messages are those that specifically target individuals following an assessment of their unique characteristics. This systematic review assesses the evidence regarding the effectiveness of tailoring within eHealth interventions aimed at chronic disease management. OVID Medline/Embase databases were searched for randomised control trials, controlled clinical, trials, before -after studies, and time series analyses from inception - May 2014. Objectively measured clinical processes/outcomes were considered. Twenty-two papers were eligible for inclusion: 6/22 used fully tailored messaging and 16/22 used partially tailored messages. Two studies isolated tailoring as the active component. The remainder compared intervention with standard care. In all, 12/16 studies measuring clinical processes and 2/6 studies reporting clinical outcomes showed improvements, regardless of target group. Study quality was low and design did not allow for identification of interventions' active component. Heterogeneity precluded meta-analysis. This review has demonstrated that there is a lack of evidence to suggest that tailoring within an eHealth context confers benefit over non-tailored eHealth interventions.